Transforming growth factor β: A potential biomarker and therapeutic target of ventricular remodeling

Yuan Ma; Hai Zou; Xing-Xing Zhu; Jie Pang; Qiang Xu; Qin-Yang Jin; Ya-Hui Ding; Bing Zhou; Dong-Sheng Huang

doi:10.18632/oncotarget.17255

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Reviews:

Transforming growth factor β: A potential biomarker and therapeutic target of ventricular remodeling

Yuan Ma, Hai Zou, Xing-Xing Zhu, Jie Pang, Qiang Xu, Qin-Yang Jin, Ya-Hui Ding, Bing Zhou and Dong-Sheng Huang _

PDF | HTML | How to cite

Oncotarget. 2017; 8:53780-53790. https://doi.org/10.18632/oncotarget.17255

Metrics: PDF 2325 views | HTML 4587 views | ?

Abstract

Yuan Ma1,5,*, Hai Zou1,5,*, Xing-Xing Zhu2,5,*, Jie Pang1,5, Qiang Xu1,5, Qin-Yang Jin1,5, Ya-Hui Ding1,5, Bing Zhou3,5 and Dong-Sheng Huang4,5

1Department of Cardiology, Zhejiang Provincial People's Hospital, Hangzhou, China

2Department of Nephrology, Zhejiang Provincial People's Hospital, Hangzhou, China

3Department of Cardiac Surgery, Zhejiang Provincial People's Hospital, Hangzhou, China

4Department of Hepatobiliary Surgery, Zhejiang Provincial People's Hospital, Hangzhou, China

5People’s Hospital of Hangzhou Medical College, Hangzhou, China

*Co-first authors

Correspondence to:

Bing Zhou, email: [email protected]

Ya-Hui Ding, email: [email protected]

Hai Zou, email: [email protected]

Dong-Sheng Huang, email: [email protected]

Keywords: transforming growth factor β, myocardial fibrosis, ventricular remodeling, mechanism, targets

Received: February 06, 2017 Accepted: April 11, 2017 Published: April 19, 2017

ABSTRACT

Transforming growth factor β (TGF-β) is a multifunctional cytokine that is synthesized by many types of cells and regulates the cell cycle. Increasing evidence has led to TGF-β receiving increased and deserved attention in recent years because it may play a potentially novel and critical role in the development and progression of myocardial fibrosis and the subsequent progress of ventricular remodeling (VR). Numerous studies have highlighted a crucial role of TGF-β in VR and suggest potential therapeutic targets of the TGF-β signaling pathways for VR. Changes in TGF-β activity may elicit anti-VR activity and may serve as a novel therapeutic target for VR therapy. This review we discusses the smad-dependent signaling pathway, such as TGF-β/Smads, TGF-β/Sirtuins, TGF-β/BMP, TGF-β/miRNAs, TGF-β/MAPK, and Smad-independent signaling pathway of TGF-β, such as TGF-β/PI3K/Akt, TGF-β/Rho/ROCK,TGF-β/Wnt/β-catenin in the cardiac fibrosis and subsequent progression of VR. Furthermore, agonists and antagonists of TGF-β as potential therapeutic targets in VR are also described.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 17255

Publication Alerts

Reviews:

Transforming growth factor β: A potential biomarker and therapeutic target of ventricular remodeling

Abstract